undefined
The trademark MITOSKIN was filed by Asiros A/S, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on March 30, 2015, and received undefined oppositions.
There are undefined Oppositions claimed against trademark.
The first opposition filed on June 30, 2015 by Medac Gesellschaft für klinische Spezialpräparate m.b.H. on Likelihood of confusion. the opponent was represented by UEXKÜLL & STOLBERG PARTNERSCHAFT VON PATENT- UND RECHTSANWÄLTEN MBB and its proceedings were handled in English The second opposition filed on May 22, 2015 by Markline on Likelihood of confusion. the opponent was represented by DENNEMEYER & ASSOCIATES and its proceedings were handled in English
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
A total of undefined cancellation proceedings were initiated against the trademark registration in 2016.The first Cancellation was filed by Markline (represented by DENNEMEYER & ASSOCIATES) on July 22, 2018 and Final decision – EUTM partially cancelled.
The renewal of the trademark was recorded by the office on August 15, 2024.
Appointment and Replacement of representative of the trademark registration was recorded on February 26, 2016. Change of name and professional address of the trademark registration was recorded on December 5, 2016. Application for revocation or for a declaration of invalidity of the trademark registration was recorded on February 21, 2017. Change of name and professional address of the trademark registration was recorded on May 16, 2018. Decisions on applications for revocation or for a declaration of invalidity of the trademark registration was recorded on August 7, 2018.
The Opposition with reference B 002528852 was rejected according to Article 8(1)(b) CTMR with decision issued on May 31, 2016 by the EUIPO. The Cancellation with reference B 000014454 was EUTM partially cancelled according to Article 8(1)(b) CTMR with decision issued on April 17, 2018 by the EUIPO.